Market Place
Sourcing Support
Maravai Life Plans Acquisition of Officinae Bio DNA/RNA Business
07 Nov 2024 //
BUSINESSWIRE
Maravai LifeSciences Reports Q3 2024 Financial Results
07 Nov 2024 //
GLOBENEWSWIRE
Maravai LifeSciences To Host Earnings Conference Call on Nov 7, 2024
15 Oct 2024 //
GLOBENEWSWIRE
Codexis License Enzyme Portfolio to Alphazyme LLC, part of Maravai
01 Oct 2024 //
GLOBENEWSWIRE
Maravai LifeSciences Announces Upcoming Investor Conferences
12 Aug 2024 //
GLOBENEWSWIRE
Maravai LifeSciences Reports Second Quarter 2024 Financial Results
07 Aug 2024 //
GLOBENEWSWIRE
Maravai LifeSciences Appoints Trey Martin to Board of Directors
29 Jul 2024 //
GLOBENEWSWIRE
Maravai LifeSciences Schedules Q2 Earnings Call For August 7, 2024
10 Jul 2024 //
GLOBENEWSWIRE
Maravai Lifesciences Releases 2023 ESG Report
02 Jul 2024 //
GLOBENEWSWIRE
TriLink Invests in New RNA Innovation Center at Johns Hopkins
13 May 2024 //
CONTRACT PHARMA
Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
09 May 2024 //
GLOBENEWSWIRE
Maravai LifeSciences Reports First Quarter 2024 Financial Results
08 May 2024 //
GLOBENEWSWIRE
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
10 Apr 2024 //
GLOBENEWSWIRE
Maravai LifeSciences Announces March 2024 Investor Conference Schedule
12 Mar 2024 //
GLOBENEWSWIRE
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
22 Feb 2024 //
GLOBENEWSWIRE
Maravai Life To Host Earnings Conference Call on Thursday, February 22, 2024
29 Jan 2024 //
GLOBENEWSWIRE
Maravai LifeSciences Reports Third Quarter 2023 Financial Results
07 Nov 2023 //
GLOBENEWSWIRE
Maravai Life To Host Earnings Conference Call on Tuesday, November 7, 2023
17 Oct 2023 //
GLOBENEWSWIRE
Maravai LifeSciences Hosts 2023 Investor R&D Day
29 Sep 2023 //
GLOBENEWSWIRE
Maravai Chief Innovation Officer Kate Broderick Named to 2023 PharmaVoice 100
19 Sep 2023 //
GLOBENEWSWIRE
Maravai LifeSciences to Host 2023 Investor R&D Day
05 Sep 2023 //
GLOBENEWSWIRE
Maravai LifeSciences Announces August 2023 Investor Conference Schedule
09 Aug 2023 //
GLOBENEWSWIRE
Maravai LifeSciences Reports Second Quarter 2023 Financial Results
07 Aug 2023 //
GLOBENEWSWIRE
Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition
27 Jul 2023 //
GLOBENEWSWIRE
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 7, 2023
24 Jul 2023 //
GLOBENEWSWIRE
Maravai LifeSciences Announces Appointment of New Director to the Board
20 Jul 2023 //
GLOBENEWSWIRE
Congressman Scott Peters Tours Maravai™s RNA manufacturing facility
06 Jun 2023 //
GLOBENEWSWIRE
Maravai LifeSciences Reports First Quarter 2023 Financial Results
08 May 2023 //
GLOBENEWSWIRE
Maravai LifeSciences To Host Earnings Conference Call on Monday, May 8, 2023
17 Apr 2023 //
GLOBENEWSWIRE
Maravai Releases 2022 Environmental, Social and Governance (ESG) Report
28 Mar 2023 //
GLOBENEWSWIRE
Maravai LifeSciences Announces March 2023 Investor Conference Schedule
08 Mar 2023 //
GLOBENEWSWIRE
Maravai LifeSciences Reports Fourth Quarter and Full Year 2022 Financial Results
22 Feb 2023 //
GLOBENEWSWIRE
Maravai to Host Earnings Conference Call on Wednesday, February 22, 2023
01 Feb 2023 //
GLOBENEWSWIRE
Maravai LifeSciences Announces Updated CEO Leadership Transition Plans
01 Dec 2022 //
GLOBENEWSWIRE
Genezen Appoints Jeff Whitmore as Chief Commercial Officer
29 Nov 2022 //
CONTRACTPHARMA
Maravai LifeSciences Named to the 2022 Deloitte Technology Fast 500™ List
16 Nov 2022 //
GLOBENEWSWIRE
Maravai LifeSciences Announces November and December 2022 Investor
03 Nov 2022 //
GLOBENEWSWIRE
Maravai LifeSciences Reports Third Quarter 2022 Financial Results
02 Nov 2022 //
GLOBENEWSWIRE
Maravai Temporarily Reinstates Carl Hull as CEO Amidst
19 Oct 2022 //
GLOBENEWSWIRE
Maravai To Host Earnings Conference Call on Wednesday, November 2, 2022
18 Oct 2022 //
GLOBENEWSWIRE
Maravai LifeSciences Holdings Enters Oversold Territory (MRVI)
11 Oct 2022 //
NASDAQ
Maravai LifeSciences Announces CEO Leadership Transition
03 Oct 2022 //
GLOBENEWSWIRE
TriLink BioTechnologies, Part of Maravai LifeSciences, Expands its Mrna
13 Sep 2022 //
GLOBENEWSWIRE
Maravai LifeSciences Announces September 2022 Investor Conference Schedule
15 Aug 2022 //
GLOBENEWSWIRE
Maravai Lifesciences Reports Second Quarter 2022 Financial Results
04 Aug 2022 //
GLOBENEWSWIRE
Maravai LifeSciences To Host Earnings Conference Call on August 4
19 Jul 2022 //
GLOBENEWSWIRE
TriLink Bio, part of Maravai LifeSciences, Expands R&D Leadership Team
06 Jul 2022 //
GLOBENEWSWIRE
TriLink BioTech Announces Cooperative Agreement With Department of Defense
24 May 2022 //
GLOBENEWSWIRE
Maravai LifeSciences Announces May and June 2022 Investor Conference Schedule
11 May 2022 //
GLOBENEWSWIRE
Maravai LifeSciences Reports First Quarter 2022 Financial Results
05 May 2022 //
GLOBENEWSWIRE
Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 5, 2022
21 Apr 2022 //
GLOBENEWSWIRE
Bio-Techne And Cygnus Introduce New Simple Plex Hek 293 Hcp 3g Immunoassay
12 Apr 2022 //
PRNEWSWIRE
Maravai LifeSciences says March 2022 Investor Conference Schedule
09 Mar 2022 //
GLOBENEWSWIRE
Sartorius in $11B bid for COVID vaccine reagent vendor Maravai -sources
26 Feb 2022 //
REUTERS
Maravai LifeSciences Reports Q4 and Full Year 2021 Financial Results
23 Feb 2022 //
GLOBENEWSWIRE
As pockets fill with cash, Maravai spends $240M to ensure pure mRNA production
29 Jan 2022 //
ENDPTS
Maravai LifeSciences Announces Upcoming Investor Events
25 Jan 2022 //
GLOBENEWSWIRE
Maravai LifeSciences Announces Debt Repricing
20 Jan 2022 //
GLOBENEWSWIRE
Maravai LifeSciences Added to the Nasdaq Biotechnology Index
14 Dec 2021 //
GLOBENEWSWIRE
Maravai LifeSciences Announces Establishment of New Charitable Foundation
09 Dec 2021 //
GLOBENEWSWIRE
